This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Jul;3(7):561-3.

Rational 'DOTS plus' for the control of MDR-TB

M A Espinal¹, C Dye, M Raviglione, A Kochi

Affiliations

PMID: 10423218

Review

Rational 'DOTS plus' for the control of MDR-TB

M A Espinal et al. Int J Tuberc Lung Dis. 1999 Jul.

. 1999 Jul;3(7):561-3.

Authors

M A Espinal¹, C Dye, M Raviglione, A Kochi

Affiliation

¹ Communicable Disease Surveillance and Response, World Health Organization, Geneva, Switzerland.

PMID: 10423218

No abstract available

PubMed Disclaimer

Comment in

Management of MDR-TB in resource-poor countries.
Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Farmer P, et al. Int J Tuberc Lung Dis. 1999 Aug;3(8):643-5. Int J Tuberc Lung Dis. 1999. PMID: 10460095 No abstract available.
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Gupta R, Espinal MA, Raviglione MC. Gupta R, et al. Int J Tuberc Lung Dis. 2000 Nov;4(11):1089-91. Int J Tuberc Lung Dis. 2000. PMID: 11092726 No abstract available.

Similar articles

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A, Gowda DK, Frieden TR. Pablos-Mendez A, et al. Bull World Health Organ. 2002;80(6):489-95; discussion 495-500. Bull World Health Organ. 2002. PMID: 12132008 Free PMC article.
Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
Grosset PJ. Grosset PJ. Int J Tuberc Lung Dis. 1999 Jul;3(7):549-50. Int J Tuberc Lung Dis. 1999. PMID: 10423215 No abstract available.
Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.
Kimerling ME, Kluge H, Vezhnina N, Iacovazzi T, Demeulenaere T, Portaels F, Matthys F. Kimerling ME, et al. Int J Tuberc Lung Dis. 1999 May;3(5):451-3. Int J Tuberc Lung Dis. 1999. PMID: 10331736
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
Gupta R, Raviglione MC, Espinal MA. Gupta R, et al. Int J Tuberc Lung Dis. 2001 Dec;5(12):1078-9. Int J Tuberc Lung Dis. 2001. PMID: 11769764 Review. No abstract available.
Management of multi-drug resistant tuberculosis: practitioner's view point.
Prasad R. Prasad R. Indian J Tuberc. 2007 Jan;54(1):3-11. Indian J Tuberc. 2007. PMID: 17455417 Review.

See all similar articles

Cited by

Tuberculosis-a World Health Organization Perspective.
Sotgiu G, Sulis G, Matteelli A. Sotgiu G, et al. Microbiol Spectr. 2017 Jan;5(1):10.1128/microbiolspec.tnmi7-0036-2016. doi: 10.1128/microbiolspec.TNMI7-0036-2016. Microbiol Spectr. 2017. PMID: 28185618 Free PMC article. Review.
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis.
Sterling TR, Lehmann HP, Frieden TR. Sterling TR, et al. BMJ. 2003 Mar 15;326(7389):574. doi: 10.1136/bmj.326.7389.574. BMJ. 2003. PMID: 12637401 Free PMC article.
The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.
Javadi MR, Abtahi B, Gholami K, Safari Moghadam B, Tabarsi P, Salamzadeh J. Javadi MR, et al. Iran J Pharm Res. 2011 Fall;10(4):905-11. Iran J Pharm Res. 2011. PMID: 24250429 Free PMC article.
Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003-2013.
Shah NS, Grace Lin SY, Barry PM, Cheng YN, Schecter G, Desmond E. Shah NS, et al. Open Forum Infect Dis. 2016 Aug 24;3(3):ofw150. doi: 10.1093/ofid/ofw150. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27704008 Free PMC article.
Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays.
Martin A, Palomino JC, Portaels F. Martin A, et al. J Clin Microbiol. 2005 Apr;43(4):1612-6. doi: 10.1128/JCM.43.4.1612-1616.2005. J Clin Microbiol. 2005. PMID: 15814974 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc